SUSQUEHANNA INTERNATIONAL GROUP, LLP - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 123 filers reported holding KALA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$16,000
-93.5%
52,513
-70.4%
0.00%
Q1 2022$246,000
-41.7%
177,561
-49.1%
0.00%
Q4 2021$422,000
-50.1%
348,646
+8.1%
0.00%
Q3 2021$845,000
-63.2%
322,415
-25.6%
0.00%
Q2 2021$2,297,000
-46.4%
433,506
-31.8%
0.00%
Q1 2021$4,282,000
-50.2%
635,292
-49.9%
0.00%
Q4 2020$8,592,000
+96.7%
1,267,224
+117.5%
0.00%
-100.0%
Q3 2020$4,369,000
+91.0%
582,563
+167.7%
0.00%
Q2 2020$2,287,000
-47.1%
217,634
-55.7%
0.00%
-100.0%
Q1 2020$4,322,000
+483.3%
491,600
+144.7%
0.00%
Q4 2019$741,000
+16.1%
200,935
+19.9%
0.00%
Q3 2019$638,000
+49.8%
167,539
+151.6%
0.00%
Q2 2019$426,000
-7.6%
66,600
-29.4%
0.00%
Q4 2018$461,000
+17.0%
94,300
+136.3%
0.00%
Q3 2018$394,000
-69.6%
39,900
-57.7%
0.00%
Q2 2018$1,297,000
+52.6%
94,400
+75.8%
0.00%
Q1 2018$850,000
+282.9%
53,700
+451.3%
0.00%
Q3 2017$222,0009,7400.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
CAXTON CORP 1,142,360$7,745,0004.83%
RA Capital Management 10,874,613$73,730,0001.03%
Mesirow Financial Investment Management, Inc. 43,431$294,462,0000.93%
Parkman Healthcare Partners LLC 272,445$1,847,0000.47%
Samsara BioCapital, LLC 601,162$4,076,0000.41%
SILVERARC CAPITAL MANAGEMENT, LLC 102,198$693,0000.40%
Eventide Asset Management 3,450,000$23,391,0000.36%
Orbimed Advisors 5,465,030$37,053,0000.32%
Vivo Capital, LLC 786,883$5,335,0000.24%
Knights of Columbus Asset Advisors LLC 169,429$1,149,0000.12%
View complete list of KALA PHARMACEUTICALS INC shareholders